Drug or treatment

Retifanlimab clinical trials

• 12Clinical trials
• 1New in 30 days
• 3Countries

Newest trials

All recruiting trials (12)

• Retifanlimab after chemoradiation for anal cancer

  This study tests whether retifanlimab can help people with anal squamous cell carcinoma who have completed chemoradiation and still have residual disease.

  Recruiting at 7 sites Phase 2 Memorial Sloan Kettering Cancer Center · Basking Ridge, New Jersey and 6 other locations · NCT07927998

• Retifanlimab With or Without DFMO for Progressive High-Grade Gliomas

  This trial tests whether retifanlimab, with or without DFMO, is safe and may help treat progressive high-grade gliomas in adults.

  Recruiting Phase 1/2 Mayo Clinic · Rochester, Minnesota · NCT07468136

• HPV DNA-guided chemoradiation with Retifanlimab for locally advanced anal cancer

  This study tests whether adjusting chemoradiation doses based on HPV ctDNA results and adding Retifanlimab after CRT can improve outcomes for adults with new, locally advanced anal cancer.

  Recruiting Phase 2 Case Comprehensive Cancer Center · Cleveland, Ohio and 1 other locations · NCT07425054

• Retifanlimab plus ruxolitinib for advanced kidney and lung cancers

  This trial will test whether taking ruxolitinib twice daily together with retifanlimab infusions every 4 weeks is safe and can help people with metastatic renal cell carcinoma or non-small cell lung cancer who progressed on prior PD-1/PD-L1 therapy.

  Recruiting Phase 1/2 University of California, San Diego · La Jolla, California · NCT07219576

• 9‑ING‑41 and retifanlimab with modified FOLFIRINOX for advanced pancreatic cancer

  This tests whether adding the GSK‑3β inhibitor 9‑ING‑41 and the PD‑1 antibody retifanlimab to modified FOLFIRINOX helps people with advanced pancreatic cancer who have not had prior systemic therapy for their advanced disease.

  Recruiting Phase 1 University of Pittsburgh · Pittsburgh, Pennsylvania · NCT06896188

• Using blood and cerebrospinal fluid tests to monitor treatment in BRAF-altered glioma

  This study is testing if a new targeted therapy can help people with a specific type of brain tumor by checking their blood and spinal fluid for signs of the tumor during treatment.

  Recruiting Early Phase 1 Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins · Baltimore, Maryland and 1 other locations · NCT06610682

• Combining two drugs to treat advanced dedifferentiated liposarcoma

  This study is testing if combining two drugs can help people with advanced dedifferentiated liposarcoma who haven't had success with other treatments.

  Recruiting at 4 sites Phase 2 Lund University Hospital · Oslo and 3 other locations · NCT06389799

• Combining axatilimab, retifanlimab, and paclitaxel for advanced solid tumors

  This study is testing a new combination of three medications to see if they can help people with advanced solid tumors feel better and improve their treatment outcomes.

  Recruiting Phase 1/2 OHSU Knight Cancer Institute · Portland, Oregon · NCT06320405

• Combining retifanlimab, bevacizumab, and radiation for recurrent glioblastoma treatment

  This study is testing whether a new combination of a drug and radiation can help people with recurring glioblastoma live longer and feel better compared to just using one of the drugs with radiation.

  Recruiting Phase 2 Academic and Community Cancer Research United · Scottsdale, Arizona and 2 other locations · NCT06160206

• Combination immunotherapy for metastatic colorectal cancer

  This study is testing a new combination of four experimental cancer drugs to see if they can help people with metastatic colorectal cancer that usually doesn't respond to standard treatments.

  Recruiting Phase 1/2 National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT06149481

• Combining carmustine wafers with retifanlimab and radiation for glioblastoma treatment

  This study is testing if combining carmustine wafers with retifanlimab and radiation can help adults with newly diagnosed glioblastoma live longer and feel better after surgery.

  Recruiting Phase 1 Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins · Baltimore, Maryland · NCT05083754

• Combining Retifanlimab with chemotherapy for advanced soft tissue sarcoma

  This study is testing if adding Retifanlimab to chemotherapy can help people with advanced soft tissue sarcoma fight their cancer better than the usual treatments.

  Recruiting Phase 1/2 Memorial Sloan Kettering Cancer Center · New York, New York · NCT04577014

Quick answers

How many clinical trials of Retifanlimab are recruiting right now?

12, as of November 12, 2026. 1 of them was first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 3 countries. The most sites are in United States (11 trials), Norway (1 trial), Sweden (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1/2: 5, Phase 2: 4, Phase 1: 2, Early Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →